SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech informs about updates on open offer

10 Dec 2015 Evaluate

Corporate Professionals Capital, on behalf of Shivalik Rasayan (Acquirer) along with Growel Capital Services, Bishnoi Exports, NIAM International, Rahul Bishnoi and Ashwani Kumar Sharma (PACs) has informed this Offer Opening Public Announcement in respect of the Open Offer to the Equity Shareholders of Medicamen Biotech (Target Company), pursuant to Regulation 18(7) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The Detailed Public Statement with respect to the aforementioned offer was made on September 24, 2015.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

294.75 5.15 (1.78%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×